IBC 293

CAS No. 306935-41-1

IBC 293( IBC293 | IBC-293 )

Catalog No. M27132 CAS No. 306935-41-1

IBC 293 is selective for GPR109B over niacin receptor GPR109A. IBC 293 is a highly selective agonist for GPR109B, a human orphan G-protein-coupled receptor expressed in adipocytes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
10MG 42 In Stock
25MG 73 In Stock
50MG 110 In Stock
100MG 147 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    IBC 293
  • Note
    Research use only, not for human use.
  • Brief Description
    IBC 293 is selective for GPR109B over niacin receptor GPR109A. IBC 293 is a highly selective agonist for GPR109B, a human orphan G-protein-coupled receptor expressed in adipocytes.
  • Description
    IBC 293 is selective for GPR109B over niacin receptor GPR109A. IBC 293 is a highly selective agonist for GPR109B, a human orphan G-protein-coupled receptor expressed in adipocytes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    IBC293 | IBC-293
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    Parasite| α4β2 nAChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    306935-41-1
  • Formula Weight
    205.217
  • Molecular Formula
    C10H11N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (487.31 mM)
  • SMILES
    CC(C)n1nnc2cc(ccc12)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tomizawa, M., and Casida, J.E.Selective toxicity of neonicotinoids attributable to specificity of insect and mammalian nicotinic receptorsAnnu. Rev. Entomol.48339-364(2003)
molnova catalog
related products
  • NOX-6-18

    NOX-6-18 (GPR132-B-160) is a highly potent and selective GPR132 antagonist with insulinotropic activity that modulates macrophage reprogramming in pancreatic islets and reduces weight gain.

  • GW-1100

    GW-1100 is a selective GPR40 and FFAR1 antagonist for the study of diabetes and metabolic diseases.

  • FTBMT

    FTBMT is a selective GPR52 agonist (EC50: 75 nM) and it also has antipsychotic and procognitive properties.